biOasis Announces Shares for Services Settlement
29. Februar 2016 21:00 ET
|
biOasis Technologies Inc.
VANCOUVER, BC --(Marketwired - February 29, 2016) - biOasis Technologies Inc. (TSX VENTURE: BTI) (OTCQB: BIOAF) (the "Company") wishes to announce its intention to issue 125,000 shares for...
biOasis Technologies Inc. to Present at the 1st Annual Neuroscience BioPartnering and Investment Forum in New York on February 23, 2016
11. Februar 2016 18:09 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - February 11, 2016) -
BIOASIS TECHNOLOGIES INC. (OTCQX: BIOAF)(TSX VENTURE: BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of...
biOasis Announces the Issuance of a US Patent for the Delivery of Therapeutic Agents Across the Blood-Brain Barrier Using Polypeptides Derived From the Transcend Protein Delivery Vector
29. November 2015 15:58 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - November 29, 2015) - biOasis Technologies Inc. (OTCQB: BIOAF) (TSX VENTURE: BTI) ("biOasis or the "Company), a pioneering biopharmaceutical company focused on...
biOasis Announces the Issuance of a Key US Patent for the Delivery Through the Blood-Brain Barrier of Therapeutic Antibodies -- Inclusive of Trastuzumab -- to Treat Her2/neu Brain Metastases
10. November 2015 17:00 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - November 10, 2015) - biOasis' Transcend Platform has shown great utility in pre-clinical animal models to deliver therapeutic compounds into the brain at sufficient...
biOasis Announces Listing on OTCQB Exchange
28. September 2015 17:16 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - September 28, 2015) - biOasis Technologies Inc. (TSX VENTURE: BTI) (OTCQB: BIOAF) (the "Company") wishes to announce, that as part of its going forward strategy, its...
biOasis Announces Extension of Share Purchase Warrants
14. August 2015 13:00 ET
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - August 14, 2015) - biOasis Technologies Inc. (TSX VENTURE: BTI) (OTCQX: BIOAF) (the "Company") wishes to announce that it will make an application to extend the exercise...
biOasis Announces the Successful Delivery to the CNS of an Enzyme Used to Treat Hunter Syndrome
31. Juli 2015 16:30 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 31, 2015) - BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF)(TSX VENTURE:BTI), a pioneering biopharmaceutical company focused on overcoming the...
biOasis Technologies Inc. and Brigham and Women's Hospital Inc., Enter a Neuro-Oncology Research & Collaboration Agreement
21. Juli 2015 17:00 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 21, 2015) - biOasis (OTCQX:BIOAF)(TSX VENTURE:BTI) and Brigham and Women's Hospital Inc. ("BWH"), Harvard Medical School's distinguished...
biOasis Engages Kilmer Lucas for Cross-Border Investor Relations
08. Juni 2015 17:00 ET
|
biOasis Technologies Inc.
RICHMOND, BRITISH COLUMBIA--(Marketwired - June 8, 2015) - BIOASIS TECHNOLOGIES INC. (OTCQX:BIOAF) (TSX VENTURE:BTI), a pioneering biopharmaceutical company focused on overcoming the...
biOasis Enters Into A Collaborative Research and Joint Funding Support Agreement Entitled "Focus on Brain"
27. Mai 2015 09:00 ET
|
biOasis Technologies Inc.
VANCOUVER, BRITISH COLUMBIA--(Marketwired - May 27, 2015) - biOasis (TSX VENTURE:BTI)(OTCQX:BIOAF) today announces that it, in partnership with the National Research Council of Canada and...